|
1
|
Wan G, Tao JG, Wang GD, Liu SP, Zhao HX
and Liang QD: In vitro antitumor activity of the ethyl
acetate extract of Potentilla chinensis in osteosarcoma
cancer cells. Mol Med Rep. 14:3634–3640. 2016.PubMed/NCBI
|
|
2
|
Meng ZJ, Wu N, Liu Y, Shu KJ, Zou X, Zhang
RX, Pi CJ, He BC, Ke ZY, Chen L, et al: Evodiamine inhibits the
proliferation of human osteosarcoma cells by blocking PI3K/Akt
signaling. Oncol Rep. 34:1388–1396. 2015.PubMed/NCBI
|
|
3
|
Scholten DJ II, Timmer CM, Peacock JD,
Pelle DW, Williams BO and Steensma MR: Down regulation of Wnt
signaling mitigates hypoxia-induced chemoresistance in human
osteosarcoma cells. PLoS One. 9:e1114312014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pruksakorn D, Teeyakasem P, Klangjorhor J,
Chaiyawat P, Settakorn J, Diskul-Na-Ayudthaya P, Chokchaichamnankit
D, Pothacharoen P and Srisomsap C: Overexpression of KH-type
splicing regulatory protein regulates proliferation, migration, and
implantation ability of osteosarcoma. Int J Oncol. 49:903–912.
2016.PubMed/NCBI
|
|
5
|
Ma K, Huang MY, Guo YX and Hu GQ:
Matrine-induced autophagy counteracts cell apoptosis via the ERK
signaling pathway in osteosarcoma cells. Oncol Lett. 12:1854–1860.
2016.PubMed/NCBI
|
|
6
|
Sarman H, Bayram R and Benek SB:
Anticancer drugs with chemotherapeutic interactions with
thymoquinone in osteosarcoma cells. Eur Rev Med Pharmacol Sci.
20:1263–1270. 2016.PubMed/NCBI
|
|
7
|
Wei X, Qu TL, Yang YF, Xu JF, Li XW, Zhao
ZB and Guo YW: Design and synthesis of new tetrandrine derivatives
and their antitumor activities. J Asian Nat Prod Res. 18:966–975.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu T, Liu X and Li W: Tetrandrine, a
Chinese plant-derived alkaloid, is a potential candidate for cancer
chemotherapy. Oncotarget. 7:40800–40815. 2016.PubMed/NCBI
|
|
9
|
Lei RR, Hu HF, Bai F, Liu Y, Wu CZ, Huang
XX, Xie LP and Hu YJ: Anti-proliferative and apoptotic effects of
S1, a tetrandrine derivative, in human gastric cancer BGC-823
cells. Chin J Nat Med. 14:527–533. 2016.PubMed/NCBI
|
|
10
|
Zhang Y, Liu W, He W, Zhang Y, Deng X, Ma
Y, Zeng J and Kou B: Tetrandrine reverses epithelial-mesenchymal
transition in bladder cancer by downregulating Gli-1. Int J Oncol.
48:2035–2042. 2016.PubMed/NCBI
|
|
11
|
Li D, Lu Y, Sun P, Feng LX, Liu M, Hu LH,
Wu WY, Jiang BH, Yang M, Qu XB, et al: Inhibition on proteasome β1
subunit might contribute to the anti-cancer effects of
fangchinoline in human prostate cancer cells. PLoS One.
10:e01416812015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wu K, Zhou M, Wu QX, Yuan SX, Wang DX, Jin
JL, Huang J, Yang JQ, Sun WJ, Wan LH, et al: The role of IGFBP-5 in
mediating the anti-proliferation effect of tetrandrine in human
colon cancer cells. Int J Oncol. 46:1205–1213. 2015.PubMed/NCBI
|
|
13
|
Zhu R, Liu T, Tan Z, Wu X, Li M, Jiang L,
Bao R, Shu Y, Lu A and Liu Y: Tetrandrine induces apoptosis in
gallbladder carcinoma in vitro. Int J Clin Pharmacol Ther.
52:900–905. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tian Y, Yin H and Xu H: Enhanced
pro-apoptotic effect of tetrandrine loaded nanoparticles against
osteosarcoma cells. Curr Drug Deliv. 13:946–952. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tao LJ, Zhou XD, Shen CC, Liang CZ, Liu B,
Tao Y and Tao HM: Tetrandrine induces apoptosis and triggers a
caspase cascade in U2-OS and MG-63 cells through the intrinsic and
extrinsic pathways. Mol Med Rep. 9:345–349. 2014.PubMed/NCBI
|
|
16
|
Shojaee S, Chan LN, Buchner M, Cazzaniga
V, Cosgun KN, Geng H, Qiu YH, von Minden MD, Ernst T, Hochhaus A,
et al: PTEN opposes negative selection and enables oncogenic
transformation of pre-B cells. Nat Med. 22:379–387. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu YL and Yan Y: Timing of the loss of
Pten protein determines disease severity in a mouse model of
myeloid malignancy. 127:1912–1922. 2016.
|
|
18
|
Johnson GL and Lapadat R:
Mitogen-activated protein kinase pathways mediated by ERK, JNK, and
p38 protein kinases. Science. 298:1911–1912. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Banerjee B, Nandi P, Chakraborty S, Raha
S, Sen PC and Jana K: Resveratrol ameliorates
benzo(a)pyrene-induced testicular dysfunction and apoptosis:
Involvement of p38 MAPK/ATF2/iNOS signaling. J Nutr Biochem.
34:17–29. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li J, Zhang J, Tang M, Xin J, Xu Y, Volk
A, Hao C, Hu C, Sun J, Wei W, et al: Hematopoietic stem cell
activity is regulated by Pten phosphorylation through a
niche-dependent mechanism. Stem Cells. 34:2130–2144. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wu QX, Yuan SX, Ren CM, Yu Y, Sun WJ, He
BC and Wu K: Oridonin upregulates PTEN through activating p38 MAPK
and inhibits proliferation in human colon cancer cells. Oncol Rep.
35:3341–3348. 2016.PubMed/NCBI
|
|
22
|
Luo J, Deng ZL, Luo X, Tang N, Song WX,
Chen J, Sharff KA, Luu HH, Haydon RC, Kinzler KW, et al: A protocol
for rapid generation of recombinant adenoviruses using the AdEasy
system. Nat Protoc. 2:1236–1247. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rhei E, Kang L, Bogomolniy F, Federici MG,
Borgen PI and Boyd J: Mutation analysis of the putative tumor
suppressor gene PTEN/MMAC1 in primary breast carcinomas.
Cancer Res. 57:3657–3659. 1997.PubMed/NCBI
|
|
24
|
Wang L, Wang W, Rui Z and Zhou D: The
effective combination therapy against human osteosarcoma:
Doxorubicin plus curcumin co-encapsulated lipid-coated polymeric
nanoparticulate drug delivery system. Drug Deliv. 23:3200–3208.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bhagya N and Chandrashekar KR: Tetrandrine
- A molecule of wide bioactivity. Phytochemistry. 125:5–13. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xiao W, Jiang Y, Men Q, Yuan L, Huang Z,
Liu T, Li W and Liu X: Tetrandrine induces G1/S cell cycle arrest
through the ROS/Akt pathway in EOMA cells and inhibits angiogenesis
in vivo. Int J Oncol. 46:360–368. 2015.PubMed/NCBI
|
|
27
|
Chiou WF, Lee WS and Yeh PH: Tetrandrine
selectively protects against amyloid-beta protein - but not against
MPTP-induced cytotoxicity in SK-N-SH neuroblastoma cells. Planta
Med. 72:1300–1304. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shen YC, Chen CF, Wang SY and Sung YJ:
Impediment to calcium influx and reactive oxygen production
accounts for the inhibition of neutrophil Mac-1 Up-regulation and
adhesion by tetrandrine. Mol Pharmacol. 55:186–193. 1999.PubMed/NCBI
|
|
29
|
Oh SH and Lee BH: Induction of apoptosis
in human hepatoblastoma cells by tetrandrine via caspase-dependent
Bid cleavage and cytochrome c release. Biochem Pharmacol.
66:725–731. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xu M, Sheng LH, Zhu XH, Zeng SB and Zhang
GJ: Reversal effect of Stephania tetrandra-containing Chinese herb
formula SENL on multidrug resistance in lung cancer cell line
SW1573/2R120. Am J Chin Med. 38:401–413. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xing ZB, Yao L, Zhang GQ, Zhang XY, Zhang
YX and Pang D: Fangchinoline inhibits breast adenocarcinoma
proliferation by inducing apoptosis. Chem Pharm Bull. 59:1476–1480.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chaudhary P and Vishwanatha JK: c-Jun
NH2-terminal kinase-induced proteasomal degradation of
c-FLIPL/S and Bcl2 sensitize prostate cancer
cells to Fas- and mitochondria-mediated apoptosis by tetrandrine.
Biochem Pharmacol. 91:457–473. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fallahabadi ZR, Daloii Noori MR, Mahdian
R, Behjati F, Shokrgozar MA, Abolhasani M, Asgari M and Shahrokh H:
Frequency of PTEN alterations, TMPRSS2-ERG fusion and their
association in prostate cancer. Gene. 575:755–760. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liang N, Zhou X, Zhao M, Zhao D, Zhu Z, Li
S and Yang H: Down-regulation of microRNA-26b modulates non-small
cell lung cancer cells chemoresistance and migration through the
association of PTEN. Acta Biochim Biophys Sin. 47:530–538. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mi S, Xiang G, Yuwen D, Gao J, Guo W, Wu
X, Wu X, Sun Y, Su Y, Shen Y, et al: Inhibition of autophagy by
andrographolide resensitizes cisplatin-resistant non-small cell
lung carcinoma cells via activation of the Akt/mTOR pathway.
Toxicol Appl Pharmacol. 310:78–86. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xiong J, Li Z, Zhang Y, Li D, Zhang G, Luo
X, Jie Z, Liu Y, Cao Y, Le Z, et al: PRL-3 promotes the peritoneal
metastasis of gastric cancer through the PI3K/Akt signaling pathway
by regulating PTEN. Oncol Rep. 36:1819–1828. 2016.PubMed/NCBI
|
|
37
|
Šrámek J, Němcová-Fürstová V and Kovář J:
Kinase signaling in apoptosis induced by saturated fatty acids in
pancreatic β-cells. Int J Mol Sci. 17:172016. View Article : Google Scholar
|
|
38
|
Segalés J, Perdiguero E and Muñoz-Cánoves
P: Regulation of muscle stem cell functions: A focus on the p38
MAPK signaling pathway. Front Cell Dev Biol. 4:912016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang L, Bai YY, Yang Y, Hu F, Wang Y, Yu
Z, Cheng Z and Zhou J: Diabetes mellitus stimulates pancreatic
cancer growth and epithelial-mesenchymal transition-mediated
metastasis via a p38 MAPK pathway. Oncotarget. 7:38539–38550.
2016.PubMed/NCBI
|
|
40
|
Su CC, Chen JY, Din ZH, Su JH, Yang ZY,
Chen YJ, Wang RY and Wu YJ: 13-acetoxysarcocrassolide induces
apoptosis on human gastric carcinoma cells through
mitochondria-related apoptotic pathways: p38/JNK activation and
PI3K/AKT suppression. Mar Drugs. 12:5295–5315. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Benvenuto M, Mattera R, Masuelli L,
Taffera G, Andracchio O, Tresoldi I, Lido P, Giganti MG, Godos J,
Modesti A, et al: (±)-Gossypol induces apoptosis and autophagy in
head and neck carcinoma cell lines and inhibits the growth of
transplanted salivary gland cancer cells in BALB/c mice. Int
J Food Sci Nutr. 1–15. 2016.
|
